Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Revenue (2016 - 2025)

Historic Revenue for BioCorRx (BICX) over the last 15 years, with Q3 2025 value amounting to $635224.0.

  • BioCorRx's Revenue changed N/A to $635224.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $948361.0, marking a year-over-year increase of 346486.49%. This contributed to the annual value of $7665.0 for FY2024, which is 9140.31% down from last year.
  • According to the latest figures from Q3 2025, BioCorRx's Revenue is $635224.0.
  • Over the past 5 years, BioCorRx's Revenue peaked at $635224.0 during Q3 2025, and registered a low of $3620.0 during Q1 2024.
  • For the 5-year period, BioCorRx's Revenue averaged around $76899.9, with its median value being $18938.0 (2023).
  • As far as peak fluctuations go, BioCorRx's Revenue plummeted by 9104.89% in 2024, and later surged by 430637.82% in 2025.
  • Over the past 5 years, BioCorRx's Revenue (Quarter) stood at $13613.0 in 2021, then surged by 508.83% to $82880.0 in 2022, then plummeted by 77.15% to $18938.0 in 2023, then plummeted by 78.64% to $4045.0 in 2024, then surged by 15603.93% to $635224.0 in 2025.
  • Its last three reported values are $635224.0 in Q3 2025, $178238.0 for Q2 2025, and $134899.0 during Q1 2025.